NOVONIX (NASDAQ:NVX) Stock Price Down 3.7% – Time to Sell?

NOVONIX Limited Sponsored ADR (NASDAQ:NVX)’s share price was down 3.7% during mid-day trading on Monday . The company traded as low as $0.6410 and last traded at $0.6550. Approximately 558,316 shares were traded during mid-day trading, an increase of 25% from the average daily volume of 445,181 shares. The stock had previously closed at $0.68.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of NOVONIX in a research report on Thursday, January 22nd. Wall Street Zen downgraded shares of NOVONIX from a “hold” rating to a “sell” rating in a report on Saturday, March 7th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Sell”.

NOVONIX Price Performance

The company has a quick ratio of 1.04, a current ratio of 1.07 and a debt-to-equity ratio of 0.23. The company has a fifty day moving average price of $0.89 and a two-hundred day moving average price of $1.21.

NOVONIX (NASDAQ:NVX) last released its earnings results on Thursday, January 29th. The company reported ($0.22) earnings per share (EPS) for the quarter. The company had revenue of $1.40 million during the quarter. As a group, sell-side analysts forecast that NOVONIX Limited Sponsored ADR will post -0.44 EPS for the current fiscal year.

Institutional Investors Weigh In On NOVONIX

Several large investors have recently made changes to their positions in the stock. GK Wealth Management LLC bought a new position in shares of NOVONIX in the fourth quarter valued at $26,000. OLD Mission Capital LLC acquired a new position in NOVONIX during the fourth quarter worth $32,000. Southeast Asset Advisors LLC bought a new stake in NOVONIX during the third quarter worth $35,000. Susquehanna International Group LLP acquired a new stake in NOVONIX in the third quarter valued at $65,000. Finally, XY Capital Ltd acquired a new stake in NOVONIX in the fourth quarter valued at $66,000. Institutional investors and hedge funds own 0.06% of the company’s stock.

About NOVONIX

NOVONIX, trading under the NASDAQ ticker NVX, is a technology-driven company specializing in the development and production of advanced materials and testing solutions for the lithium-ion battery industry. The company’s primary focus lies in supplying high-purity synthetic graphite anode materials and delivering comprehensive battery testing services to original equipment manufacturers (OEMs), research institutions, and battery producers worldwide. NOVONIX operates through two core divisions: NOVONIX Materials & Technology, which produces battery-grade graphite, and NOVONIX Battery Testing Solutions, which offers hardware and software platforms designed to accelerate battery research and development.

The Materials & Technology business segment manufactures spherical synthetic graphite anode products that meet rigorous industry standards for performance, consistency, and scalability.